- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02923232
Ocular Adaptation and Visual Performance for Accommodative Contact Lens (ACL)
April 28, 2023 updated by: Shun-nan Yang, Pacific University
Presbyopes (people who might have a significant loss of their ability to accommodate their crystalline lens in the eye) will be recruited to wear a test lens and perform typical clinical tests of visual acuity with different luminance levels and viewing distances/angles.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
In the proposed study we plan to recruit presbyopes (people who might have a significant loss of their ability to accommodate their crystalline lens in the eye) to wear a test lens and perform typical clinical tests of visual acuity with different luminance levels and viewing distances/angles.
These are similar to the typical examinations conducted for regular contact lens wearers.
Results of this testing will be used to evaluate the efficacy of test lenses and to provide additional information for revision of test lenses.
If shown to provide adequate eye comfort and intended vision correction, this lens design has the potential of allowing tens of millions of presbyopes to adapt to contact lenses and significantly improve their vision and well-being.
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Forest Grove, Oregon, United States, 97116
- Vision Performance Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Be between 40 and 65 years of age.
- Have normal/corrected-to-normal monocular acuity of better than 20/25 for both eyes.
- Have pupil diameter in regular lighting ≥ 2.5 mm.
- Willing and able to wear multifocal contact lenses in both eyes.
- Have a current optical prescription (obtained less than 2 years ago).
- Have spherical equivalent correction equal to or higher than -1.00 Diopter and equal to or less than +0.50 Diopter.
- Have cylindrical correction equal to less than 0.50 Diopter.
Exclusion Criteria:
- Have no prismatic correction.
- Without any eye infection, inflammation, disease, or abnormality that contraindicates contact lens wear within the past 6 months.
- No clinically significant ocular pathology (e.g., cataract, keratoconus, dry eye, diabetic retinopathy, or age-related macular degeneration)
- Have no photosensitive disorders, including migraine and seizure.
- Have no binocular dysfunction, including amblyopia, strabismus, and other binocular diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Accommodative contact lens
The accommodative contact lens is composed of traditional hydrogel lens material but has an internal cavity to allow lens deformation that increases its refractive power at an downward angle.
|
Different downgaze angles will be experimented to determine whether the accommodative contact lens can alter its optical refraction at downgaze angles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Monocular Refractive Power
Time Frame: 30 mins of wearing; non-dispensing.
|
Participants will wear the test lens and look at different downsize angles.
The refractive power of the lens/eye combination will be measured with an open-field auto refractor.
|
30 mins of wearing; non-dispensing.
|
|
Visual Acuity at 20 Degree Downsize Angles
Time Frame: 30 mins of wearing; non-dispensing.
|
The resultant visual acuity at near at this down-gaze angle will be measured.
This is achieved by having the subjects holding a new acuity chart at 40 cm distance, their heads upright and perpendicular to the ground, and their gazes rotated downward 20 degrees where the chart was located.
The subjects then read out the optotypes (letters) on the chart to a size they cannot no only identify the letters.
The lines of letters with which all letters can be identified is recorded as the corresponding level of acuity.
|
30 mins of wearing; non-dispensing.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
March 1, 2020
Study Completion (Actual)
March 1, 2020
Study Registration Dates
First Submitted
September 29, 2016
First Submitted That Met QC Criteria
October 2, 2016
First Posted (Estimate)
October 4, 2016
Study Record Updates
Last Update Posted (Actual)
May 3, 2023
Last Update Submitted That Met QC Criteria
April 28, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- OFV-S1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functionality of Experimental Contact Lens
-
EV Clinical TrialsCompletedContact Lens Discomfort | Contact Lens | Contact Lens DrynessUnited States
-
Bausch & Lomb IncorporatedCompletedAdverse Effect of Contact Lens SolutionMalaysia
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Aston UniversityCooperVision, Inc.Enrolling by invitationContact Lens Wear | Healthy Participants Study | Contact Lens FitUnited Kingdom
-
Ohio State UniversityCompletedContact LensUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
Ohio State UniversityAlcon ResearchCompleted
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
University Hospital, CaenNot yet recruitingContact Lens ComplicationFrance
Clinical Trials on Accommodative contact lens
-
CIBA VISIONCompleted
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Bausch & Lomb IncorporatedCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
University of RochesterCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompleted